Morgan Stanley Expansion Capital Invests $24M in ValGenesis

May 4, 2021

Morgan Stanley Expansion Capital has made a $24 million growth investment in ValGenesis, a provider of cloud-based validation lifecycle management (VLMS) software for the life sciences. Proceeds will bolster sales, accelerate product innovation in digital validation technologies, and support global deployment.

Buyers
Morgan Stanley Expansion Capital
Targets
ValGenesis
Industry
Cloud & SaaS
Location
California, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.